News

Issued by Er-Kim, not Puma Biotechnology Inc

Er-Kim Announces Exclusive Distribution Agreement with Puma Biotechnology to Commercialize NERLYNX® (neratinib) for Breast Cancer Patients

April 30, 2025 · Published on GlobeNewswire

It isn’t one of Puma Biotechnology Inc’s news releases, so 6ix doesn’t show it on Puma Biotechnology Inc’s page or send it as an alert.

Go to Puma Biotechnology Inc on 6ix